Ben-Zeev, Dror
Buck, Benjamin
Kopelovich, Sarah
Meller, Suzanne
Article History
Received: 12 August 2019
Accepted: 29 August 2019
First Online: 18 September 2019
Competing interests
: Ben-Zeev owns the IP for the FOCUS intervention that is described in an article referenced in this paper. He has an intervention content licensing agreement with Pear Therapeutics and has consulted for eQuility and Otsuka. The remaining authors declare no competing interests.